Cigna Group (CI)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Symbol
CI
Exchange
NYSE
Sector
Healthcare
Industry
Healthcare Plans
Market cap
$71.41B
52 week range
239.51 - 315.47

Valuation

Share price
$270.53 (close of 2026-10-02)
P/E (TTM)
11.13x
Price to book
1.66x
Price to free cash flow
6.95x
Enterprise value
$96.03B
Book value per share
$162.56

Price performance

PeriodChange
1 day+0.96%
5 days-0.54%
1 month-4.35%
3 months-5.99%
6 months+0.19%
Year to date-1.71%
1 year-8.91%
3 years-5.92%
5 years+33.53%
10 years+107.59%
All time+4556.28%

Members of Congress who disclosed CI trades

Julie Johnson · Gilbert Ray Cisneros · Jared Moskowitz · Jefferson Shreve · Julia Letlow · Robert Bresnahan · Val Hoyle · Alan Armstrong

Super investors holding CI

Dodge & Cox (Dodge & Cox Funds) · Christopher Davis (Davis Selected Advisers) · Richard Pzena (Pzena Investment Management) · Ken Griffin (Citadel) · David Einhorn (DME Capital Management) · Ray Dalio (Bridgewater Associates) · Tweedy Browne (Tweedy Browne Company LLC)

Profitability and growth

Return on equity
14.23%
Return on invested capital
11.93%
Return on assets
3.77%
Return on capital employed
9.06%
Gross margin
21.79%
Net margin
2.17%
EBITDA margin
4.36%
Revenue growth
11.24%
Net income growth
73.47%
Free cash flow growth
-7.35%

Cash flow and balance sheet

Free cash flow yield (TTM)
14.39%
Current ratio
0.85x
Net debt to EBITDA
1.93x

Latest reported year

Period end
2025-12-31
Fiscal year
2025
Revenue
$274.90B
Cost of revenue
$214.99B
Gross profit
$59.91B
EBITDA
$11.97B
Net income
$5.96B
Earnings per share
$22.33
Shares outstanding
268.56M

Income statement by year

Period endRevenueGross profitNet incomeEPS
2025-12-31$274.90B$59.91B$5.96B$22.33
2024-12-31$247.12B$64.61B$3.43B$12.25
2023-12-31$195.26B$61.46B$5.16B$17.57
2022-12-31$180.52B$55.68B$6.78B$21.66
2021-12-31$174.07B$56.52B$5.42B$15.89
2020-12-31$160.40B$56.92B$8.49B$23.17
2019-12-31$153.57B$55.90B$5.12B$13.58
2018-12-31$48.65B$43.86B$2.65B$10.69
2017-12-31$41.81B$39.35B$2.23B$8.92
2016-12-31$39.84B$37.37B$1.84B$7.31

Margins and returns by year

Period endGross marginNet marginReturn on equityReturn on capital
2025-12-3121.79%2.17%14.23%11.93%
2024-12-3126.15%1.39%8.33%12.19%
2023-12-3131.48%2.64%11.17%12.27%
2022-12-3130.85%3.76%15.18%9.91%
2021-12-3132.47%3.11%11.54%15.08%
2020-12-3135.48%5.29%16.91%13.51%
2019-12-3136.40%3.33%11.29%14.40%
2018-12-3190.15%5.44%6.45%8.43%
2017-12-3194.13%5.34%16.28%29.04%
2016-12-3193.80%4.63%13.45%18.56%

Cash and debt by year

Period endCash
2025-12-31$8.73B
2024-12-31$8.21B
2023-12-31$8.75B
2022-12-31$6.83B
2021-12-31$6.00B
2020-12-31$11.51B
2019-12-31$5.56B
2018-12-31$5.90B
2017-12-31$5.11B

Free cash flow by year

Period endFree cash flowStock-based compensation
2025-12-31$9.60B$291.00M
2024-12-31$10.36B$308.00M
2023-12-31$11.81B$286.00M
2022-12-31$8.66B$264.00M
2021-12-31$7.19B$268.00M
2020-12-31$10.35B$289.00M
2019-12-31$8.44B$299.00M
2018-12-31$3.24B$180.00M
2017-12-31$3.62B$178.00M
2016-12-31$3.56B$128.00M

Dividend history

Most recent payment
2026-09-08
Paid in the last twelve months
$6.19
Payment dateDividend per share
2026-09-08$1.56
2026-06-04$1.56
2026-03-05$1.56
2025-12-04$1.51
2025-09-04$1.51
2025-06-03$1.51
2025-03-05$1.51
2024-12-04$1.40

Investor relations

Next earnings report

Next confirmed report
2026-10-29
Consensus EPS estimate
$7.46

Past earnings dates

ReportedFiscal periodEPS estimate
2026-07-30Jun/2026$7.58
2026-04-30Mar/2026$7.62
2026-02-05Dec/2025$7.87
2025-10-30Sep/2025$7.70
2025-07-31Jun/2025$7.14
2025-07-30--
2025-05-02Mar/2025$6.39
2025-04-30--

Filings and sources

Company website
thecignagroup.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

Humana Inc (HUM) · Elevance Health, Inc. (ELV) · Centene Corp (CNC) · CVS Health Corp (CVS) · Molina Healthcare, Inc. (MOH) · UnitedHealth Group Inc (UNH) · HCA Healthcare, Inc. (HCA) · HealthEquity, Inc. (HQY)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades